MetaCap

Gossamer Bio Statistics

NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.72-0.51 (-4.54%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Gossamer Bio by the numbers

Gossamer Bio has a market capitalization of $65.6 million based on 6.12M shares outstanding. With trailing EPS of $-42.41, Gossamer Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.0% above its 50-day average and 59.7% below its 200-day average.

Average daily trading volume is 243.40K shares, or about $2.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GOSS valuation vs. peer median

GOSS compared with the median of 8 peer companies
MetricGOSSPeer medianDifference
Market cap$65.57M$66.70M-2%
Avg. volume243.40K230.15K+6%

Peer median across 8 companies: PMVP, PLYX, FBIO, MNOV, CING, MAIA, VTVT, COYA.

Valuation

Market cap
$65.57M
Price / sales (latest FY)
1.35
EPS (TTM)
$-42.41

Price and trading

Previous close
11.23
Open
11.02
Day range
10.65 – 11.60
52-week range
8.29 – 309.60
52-week change
-95.62%
Beta
—
Volume
191.36K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
65.57M
Forward Pe
-0.88
Eps
-42.41
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
309.60
Week52 Low
8.29
Avg Volume
243.40K
Shares Outstanding
6.12M
Ma50
10.40
Ma200
26.58
Earnings Date
Nov 10, 2026
Pct From52w High
-96.54%
Pct From52w Low
29.31%

Related